These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 26821682

  • 1. Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia.
    Gumus E, Atalay MA, Cetinkaya Demir B, Sahin Gunes E.
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3806-11. PubMed ID: 26821682
    [Abstract] [Full Text] [Related]

  • 2. Middle cerebral/umbilical artery resistance index ratio as sensitive parameter for fetal well-being and neonatal outcome in patients with preeclampsia: case-control study.
    Ebrashy A, Azmy O, Ibrahim M, Waly M, Edris A.
    Croat Med J; 2005 Oct; 46(5):821-5. PubMed ID: 16158478
    [Abstract] [Full Text] [Related]

  • 3. The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and/or intrauterine fetal growth restriction.
    Laskowska M, Laskowska K, Oleszczuk J.
    J Matern Fetal Neonatal Med; 2015 Jan; 28(1):26-32. PubMed ID: 24588201
    [Abstract] [Full Text] [Related]

  • 4. Asymmetric dimethylarginine in normotensive pregnant women with isolated fetal intrauterine growth restriction: a comparison with preeclamptic women with and without intrauterine growth restriction.
    Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, Oleszczuk J.
    J Matern Fetal Neonatal Med; 2011 Jul; 24(7):936-42. PubMed ID: 21142768
    [Abstract] [Full Text] [Related]

  • 5. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
    Laskowska M, Laskowska K, Oleszczuk J.
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
    [Abstract] [Full Text] [Related]

  • 6. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
    Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, Oleszczuk J.
    J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differences in the association between maternal serum homocysteine and ADMA levels in women with pregnancies complicated by preeclampsia and/or intrauterine growth restriction.
    Laskowska M, Laskowska K, Oleszczuk J.
    Hypertens Pregnancy; 2013 Jul; 32(1):83-93. PubMed ID: 23273067
    [Abstract] [Full Text] [Related]

  • 11. Prognostic role of umbilical artery Doppler velocimetry in growth-restricted fetuses.
    Soregaroli M, Bonera R, Danti L, Dinolfo D, Taddei F, Valcamonico A, Frusca T.
    J Matern Fetal Neonatal Med; 2002 Mar; 11(3):199-203. PubMed ID: 12380678
    [Abstract] [Full Text] [Related]

  • 12. Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated with preeclampsia or had a small for gestational age baby.
    Rizos D, Eleftheriades M, Batakis E, Rizou M, Haliassos A, Hassiakos D, Botsis D.
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1311-5. PubMed ID: 22010788
    [Abstract] [Full Text] [Related]

  • 13. Altered Bioavailability of Nitric Oxide and L-Arginine Is a Key Determinant of Endothelial Dysfunction in Preeclampsia.
    Tashie W, Fondjo LA, Owiredu WKBA, Ephraim RKD, Asare L, Adu-Gyamfi EA, Seidu L.
    Biomed Res Int; 2020 Aug; 2020():3251956. PubMed ID: 33145345
    [Abstract] [Full Text] [Related]

  • 14. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [Abstract] [Full Text] [Related]

  • 15. Asymmetric dimethylarginine in the maternal and fetal circulation in preeclampsia.
    Braekke K, Ueland PM, Harsem NK, Staff AC.
    Pediatr Res; 2009 Oct; 66(4):411-5. PubMed ID: 19581842
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
    Alahakoon TI, Zhang W, Trudinger BJ, Lee VW.
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
    [Abstract] [Full Text] [Related]

  • 18. Does pre-eclampsia influence fetal cardiovascular function in early-onset intrauterine growth restriction?
    Crispi F, Comas M, Hernández-Andrade E, Eixarch E, Gómez O, Figueras F, Gratacós E.
    Ultrasound Obstet Gynecol; 2009 Dec; 34(6):660-5. PubMed ID: 19827117
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia.
    Chedraui P, Solis EJ, Bocci G, Gopal S, Russo E, Escobar GS, Hidalgo L, Pérez-López FR, Genazzani AR, Mannella P, Simoncini T.
    J Matern Fetal Neonatal Med; 2013 Feb; 26(3):226-32. PubMed ID: 23039092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.